Perrigo Free Cash Flow 2010-2024 | PRGO
Perrigo free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Perrigo Annual Free Cash Flow | |
|---|---|
| 2023 | 303.80 |
| 2022 | 210.90 |
| 2021 | 4.20 |
| 2020 | 465.80 |
| 2019 | 250.10 |
| 2018 | 490.40 |
| 2017 | 610.30 |
| 2016 | 548.70 |
| 2015 | 123.10 |
| 2015 | 718.20 |
| 2014 | 461.40 |
| 2013 | 449.70 |
| 2012 | 393.20 |
| 2011 | 274.70 |
| 2010 | 274.55 |
| 2009 | 182.33 |
| Perrigo Quarterly Free Cash Flow | |
|---|---|
| 2024-03-31 | -26.50 |
| 2023-12-31 | 303.80 |
| 2023-09-30 | 121.80 |
| 2023-06-30 | 30.90 |
| 2023-03-31 | -3.80 |
| 2022-12-31 | 210.90 |
| 2022-09-30 | 51.40 |
| 2022-06-30 | 38.30 |
| 2022-03-31 | 81.70 |
| 2021-12-31 | 4.20 |
| 2021-09-30 | 151.30 |
| 2021-06-30 | -150.50 |
| 2021-03-31 | -45.20 |
| 2020-12-31 | 465.80 |
| 2020-09-30 | 421.50 |
| 2020-06-30 | 402.60 |
| 2020-03-31 | 138.00 |
| 2019-12-31 | 250.10 |
| 2019-09-30 | 208.00 |
| 2019-06-30 | 103.60 |
| 2019-03-31 | 73.40 |
| 2018-12-31 | 490.40 |
| 2018-09-30 | 341.90 |
| 2018-06-30 | 221.40 |
| 2018-03-31 | 159.00 |
| 2017-12-31 | 610.30 |
| 2017-09-30 | 426.80 |
| 2017-06-30 | 248.10 |
| 2017-03-31 | 172.50 |
| 2016-12-31 | 548.70 |
| 2016-09-30 | 364.10 |
| 2016-06-30 | 172.60 |
| 2016-03-31 | 63.80 |
| 2015-12-31 | 123.10 |
| 2015-09-30 | 489.80 |
| 2015-06-30 | 426.40 |
| 2015-03-31 | 148.30 |
| 2014-12-31 | 419.70 |
| 2014-09-30 | 163.40 |
| 2014-06-30 | |
| 2014-03-31 | 280.80 |
| 2013-12-31 | 142.50 |
| 2013-09-30 | 62.90 |
| 2013-06-30 | |
| 2013-03-31 | 316.60 |
| 2012-12-31 | 190.30 |
| 2012-09-30 | 30.10 |
| 2012-06-30 | |
| 2012-03-31 | 225.91 |
| 2011-12-31 | 164.46 |
| 2011-09-30 | 35.19 |
| 2011-06-30 | |
| 2011-03-31 | 182.49 |
| 2010-12-31 | 92.18 |
| 2010-09-30 | -15.36 |
| 2010-06-30 | |
| 2010-03-31 | 185.88 |
| 2009-12-31 | 132.83 |
| 2009-09-30 | 28.84 |
| 2009-06-30 | |
| 2009-03-31 | 69.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.229B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.087B | 23.84 |
| Stryker (SYK) | United States | $126.041B | 30.19 |
| Medtronic (MDT) | Ireland | $109.891B | 15.56 |
| Boston Scientific (BSX) | United States | $108.712B | 34.63 |
| EssilorLuxottica (ESLOY) | France | $100.718B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.251B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
| ResMed (RMD) | United States | $31.855B | 29.91 |
| Terumo (TRUMY) | Japan | $25.103B | 35.45 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.984B | 15.96 |
| Koninklijke Philips (PHG) | Netherlands | $24.498B | 18.98 |
| Baxter (BAX) | United States | $18.319B | 13.02 |
| Insulet (PODD) | United States | $12.431B | 55.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.955B | 0.00 |
| Demant (WILYY) | Denmark | $10.100B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.908B | 25.87 |
| BellRing Brands (BRBR) | United States | $7.758B | 36.34 |
| Lantheus Holdings (LNTH) | United States | $5.261B | 13.11 |
| Haemonetics (HAE) | United States | $4.703B | 23.27 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Prestige Consumer Healthcare (PBH) | United States | $3.491B | 16.51 |
| Envista Holdings (NVST) | United States | $3.313B | 13.67 |
| QuidelOrtho (QDEL) | United States | $2.917B | 16.22 |
| Green Thumb Industries (GTBIF) | United States | $2.695B | 53.38 |
| Neogen (NEOG) | United States | $2.692B | 25.90 |
| TG Therapeutics (TGTX) | United States | $2.615B | 73.57 |
| ICU Medical (ICUI) | United States | $2.592B | 22.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.479B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.869B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.741B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.706B | 50.00 |
| InMode (INMD) | Israel | $1.542B | 8.20 |
| Warby Parker (WRBY) | United States | $1.455B | 0.00 |
| Owens & Minor (OMI) | United States | $1.406B | 12.25 |
| AdaptHealth (AHCO) | United States | $1.221B | 9.10 |
| National Vision Holdings (EYE) | United States | $1.190B | 37.88 |
| AtriCure (ATRC) | United States | $1.047B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.999B | 0.00 |
| MacroGenics (MGNX) | United States | $0.918B | 0.00 |
| Evolus (EOLS) | United States | $0.822B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.816B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.717B | 15.26 |
| Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
| Quanterix (QTRX) | United States | $0.655B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.650B | 15.28 |
| PetIQ (PETQ) | United States | $0.550B | 17.97 |
| Jin Medical (ZJYL) | China | $0.504B | 0.00 |
| Valneva SE (VALN) | France | $0.496B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.496B | 0.00 |
| Biote (BTMD) | United States | $0.466B | 8.93 |
| ZimVie (ZIMV) | United States | $0.463B | 39.47 |
| Surmodics (SRDX) | United States | $0.461B | 28.86 |
| OraSure Technologies (OSUR) | United States | $0.386B | 12.01 |
| Aurora Cannabis (ACB) | Canada | $0.371B | 0.00 |
| Cerus (CERS) | United States | $0.353B | 0.00 |
| Zynex (ZYXI) | United States | $0.329B | 44.96 |
| Sanara MedTech (SMTI) | United States | $0.286B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 27.42 |
| TriSalus Life Sciences (TLSI) | United States | $0.262B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.43 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.185B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.171B | 0.00 |
| InterCure (INCR) | Israel | $0.150B | 25.31 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 70.49 |
| FitLife Brands (FTLF) | United States | $0.138B | 22.26 |
| Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.116B | 0.00 |
| Fonar (FONR) | United States | $0.111B | 9.50 |
| MariMed (MRMD) | United States | $0.103B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.091B | 0.00 |
| Safety Shot (SHOT) | United States | $0.064B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.063B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.95 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Bright Green (BGXX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.29 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.022B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.50 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |